Researchers say the new immunotherapy drugs can target two types of evasive cancer-driving proteins

Scientific research has shown that new immunotherapy drugs can target two types of evasive cancer-driving proteins.
Scientific research has shown that new immunotherapy drugs can target two types of evasive cancer-driving proteins.